Opinion: What it’s like to live with cognitively unimpaired Alzheimer’s disease
People with cognitively unimpaired Alzheimer’s “may be asymptomatic, but they do have a disease experience,” writes Jason Karlawish.
Health – page 3
Latest
Most people haven’t heard of kratom. What is it, and who’s using it?
Few Americans are familiar with kratom, despite public health messaging and rising use. So what is it, and who's using it?
Opinion: AI depends on medical records that don’t always tell the full truth about women
“For AI to achieve its full potential in women’s health, medical records need to tell the complete story,” experts write.
STAT+: After Medicare punts RPM overhaul to 2029, advocates see window to fight back
Medicare pushed forward a controversial plan to ban hospitals from using third parties to deliver remote patient monitoring services, despite overwhelming opposition.
After cancer surgery, Pope Leo embarks on Latin America trip
Pope Leo XIV is kicking off a three-nation tour of Latin America with a visit to Uruguay, three weeks after undergoing lung cancer surgery that had put the entire trip into question.
An anti-aging drug may help protect the brain before Alzheimer's symptoms begin
A surprising new study suggests that an anti-aging drug could help protect people genetically predisposed to Alzheimer's disease. Researchers found that just four weeks of low-dose rapamycin improved brain blood flow in healthy middle-aged adults carrying the high-risk APOE4 gene variant, with women showing the strongest benefits. Because declining blood flow can occur years before Alzheimer's…
Antibiotic pollution may be key factor in honeybee colony collapses
High losses of honeybee colonies, which play a crucial role in global food production, have caused concern around the world. Many potential factors for the population declines have been cited, but a potentially significant threat to pollinator health—environmental antibiotic pollution from agricultural sources—has been largely overlooked, according to a new article published in the Journal of the…
Bird Flu Death in Washington State Renews Concern Over the Virus
The death follows reports of infections in cattle on dozens of American farms across the country over the past month and a worrying outbreak in mink.
Child dies of measles in Wisconsin’s first such death since 1990
An infant in southwestern Wisconsin has died after contracting measles, the state’s first death from the disease in 36 years.
Avian influenza spread beyond a backyard coop on an Illinois farm, analysis finds
An outbreak of highly pathogenic avian influenza virus that nearly wiped out an Illinois farmer's backyard flock also spread to a domestic cat and wild rats on the farm, an analysis of the animals by the University of Illinois Urbana-Champaign Veterinary Diagnostic Laboratory and the University of Missouri Veterinary Medical Diagnostic Laboratory found.
Wisconsin reports its first measles death in decades, the third in the U.S. this week
An infant in Wisconsin has died of measles, the state health department said — the third measles-related death reported in the U.S. this week.
Wisconsin infant dies from measles: Health officials
It’s the first measles death in the state since 1990.
DNA nanoswitches find new drug leads faster by measuring protein interactions
Researchers at the Wyss Institute at Harvard University, Boston Children's Hospital, and Harvard Medical School (HMS) have developed FIND, a drug discovery platform that searches large libraries for molecules that modulate binding interactions between two proteins. FIND uses DNA nanoswitches to select drug candidates based on their effects on these protein-protein interactions, rather than simply…
STAT+: Novartis cites cases of previously unknown tumors possibly tied to its SMA gene therapy
Novartis has acknowledged seven previously unknown instances in which tumors were found in children who were treated with its spinal muscular atrophy therapy, Zolgensma.
Is MAHA dying—or will it be reborn? What's next after crushing midterm losses?
RFK Jr.'s Make America Healthy Again movement was in trouble before voting began.
STAT+: Stunning $6M defamation verdict reverberates at MIT campus, global scientific community
The explosive court battle between a former star scientist at the Massachusetts Institute of Technology and a younger colleague continues to roil the campus community.
STAT+: Two No Surprises Act arbitrators lose government contracts to decide payment disputes
The companies are part of a system intended to protect patients from surprise medical bills.
Opinion: MAHA 1.0 is dead. MAHA 2.0 is born
MAHA 1.0 is dead. MAHA 2.0 is born, write “Why Should I Trust You?” hosts Brinda Adhikari and Tom W. Johnson
This pancreatic cancer treatment is on track for ‘one of the best drug launches of all time’
Revolution Medicines’ brand-new treatment brought in far higher sales than expected in its first few weeks on the market.
STAT+: Winners, losers, and MAHA
Democratic doctors won big, MAHA faces an uncertain future, and what the election could mean for Medicare for All.
Why Guinea-Bissau halted a controversial hepatitis vaccine trial for babies
Experts have said the US-funded trial would deny critical vaccines to thousands of infants.
STAT+: Pharmalittle: We’re reading about India’s new manufacturing rules, clinical trials in China, and more
India proposed rules requiring regulators to immediately suspend manufacturing licenses for drugs that fail quality standards in government testing
STAT+: Beyond statins, one drug lowered heart attack risk by 20%
A new study could help doctors figure out what medicine to prescribe for cholesterol when statins don't cut it: It's “answering a really challenging clinical question."
British Citizen Infected With Ebola in Congo to Be Evacuated to UK, BBC Reports
The government said the risk to the British public from the disease was low. The current outbreak in Africa has spread widely across the continent, killing more than 5,000 people.
STAT+: Medicare delays controversial RPM rule update
Despite widespread opposition, Medicare will finalize a controversial proposal that will prevent providers, such as hospitals, from using third parties to deliver remote patient monitoring services.